INTS
USDIntensity Therapeutics Inc. Common stock
$0.455-0.035 (-7.122%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.490
High
$0.503
Low
$0.430
Volume
14.52M
Company Fundamentals
Market Cap
27.3M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
30.37M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.185Current $0.455High $3.399
Related News
PR Newswire
Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal
Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.